Deutsche Bank On Pharmacyclics: 'We Do Not See Much Upside'
February 25, 2015 at 17:05 PM EST
In a report published Wednesday, Deutsche Bank analyst Robyn Karnauskas downgraded Pharmacyclics Inc. (NASDAQ: PCYC) to Hold, while ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.